malekokour

@malekokour source repo

151 skills
0 followers
15 hours ago last updated

▌
Review Nonclinical Synthesis Human Readiness · malekokour bundle
Reviews Nonclinical synthesis for human readiness evidence pack for the L3 task «Nonclinical synthesis for human readiness». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Nonclinical synthesis for human readiness and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of nonclinical synthesis for human readiness; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Outsourcing Scope Budget Deliverables · malekokour bundle
Reviews Outsourcing scope, budget and deliverables evidence pack for the L3 task «Outsourcing scope, budget and deliverables». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Outsourcing scope, budget and deliverables and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of outsourcing scope, budget and deliverables; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Parameter Plausibility Unit Integrity · malekokour bundle
Reviews Parameter plausibility and unit integrity evidence pack for the L3 task «Parameter plausibility and unit integrity». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Parameter plausibility and unit integrity and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of parameter plausibility and unit integrity; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Portfolio Review Timeline Commitments · malekokour bundle
Reviews Portfolio review and timeline commitments evidence pack for the L3 task «Portfolio review and timeline commitments». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Portfolio review and timeline commitments and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of portfolio review and timeline commitments; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Sentinel Dosing Subject Safety Design · malekokour bundle
Reviews Sentinel dosing and subject-safety design evidence pack for the L3 task «Sentinel dosing and subject-safety design». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Sentinel dosing and subject-safety design and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of sentinel dosing and subject-safety design; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Applied Regulatory Science Contribution · malekokour bundle
Reviews Applied regulatory science contribution evidence pack for the L3 task «Applied regulatory science contribution». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Applied regulatory science contribution and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of applied regulatory science contribution; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Ethics Committee Interaction Cp Content · malekokour bundle
Reviews Ethics-committee interaction on CP content evidence pack for the L3 task «Ethics-committee interaction on CP content». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Ethics-committee interaction on CP content and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of ethics-committee interaction on cp content; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Guidance Surveillance Impact Assessment · malekokour bundle
Reviews Guidance surveillance and impact assessment evidence pack for the L3 task «Guidance surveillance and impact assessment». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Guidance surveillance and impact assessment and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of guidance surveillance and impact assessment; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Model Supported Biowaiver Justification · malekokour bundle
Reviews Model-supported biowaiver justification evidence pack for the L3 task «Model-supported biowaiver justification». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Model-supported biowaiver justification and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of model-supported biowaiver justification; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Multiplicity Inference Exposure Response · malekokour bundle
Reviews Multiplicity and inference in exposure-response evidence pack for the L3 task «Multiplicity and inference in exposure-response». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Multiplicity and inference in exposure-response and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of multiplicity and inference in exposure-response; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Clinical Meaningfulness Covariate Effects · malekokour bundle
Reviews Clinical meaningfulness of covariate effects evidence pack for the L3 task «Clinical meaningfulness of covariate effects». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Clinical meaningfulness of covariate effects and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of clinical meaningfulness of covariate effects; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Computational Environment Reproducibility · malekokour bundle
Reviews Computational environment and reproducibility evidence pack for the L3 task «Computational environment and reproducibility». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Computational environment and reproducibility and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of computational environment and reproducibility; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Biopharmaceutics Ba Be Formulation Bridging · malekokour bundle
Reviews Biopharmaceutics, BA/BE and formulation bridging evidence pack for the L3 task «Biopharmaceutics, BA/BE and formulation bridging». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Biopharmaceutics, BA/BE and formulation bridging and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of biopharmaceutics, ba/be and formulation bridging; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Food Effect Gastric Ph Acid Reducing Agents · malekokour bundle
Reviews Food effect and gastric pH / acid-reducing agents evidence pack for the L3 task «Food effect and gastric pH / acid-reducing agents». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Food effect and gastric pH / acid-reducing agents and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of food effect and gastric ph / acid-reducing agents; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Line Extensions Routes Formulations Devices · malekokour bundle
Reviews Line extensions - routes, formulations, devices evidence pack for the L3 task «Line extensions - routes, formulations, devices». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Line extensions - routes, formulations, devices and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of line extensions - routes, formulations, devices; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Safety Margins Against Toxicology Exposures · malekokour bundle
Reviews Safety margins against toxicology exposures evidence pack for the L3 task «Safety margins against toxicology exposures». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Safety margins against toxicology exposures and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of safety margins against toxicology exposures; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Infectious Disease Pta Mic Target Attainment · malekokour bundle
Reviews Infectious disease - PTA and MIC target attainment evidence pack for the L3 task «Infectious disease - PTA and MIC target attainment». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Infectious disease - PTA and MIC target attainment and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of infectious disease - pta and mic target attainment; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Therapeutic Drug Monitoring Precision Dosing · malekokour bundle
Reviews Therapeutic drug monitoring and precision dosing evidence pack for the L3 task «Therapeutic drug monitoring and precision dosing». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Therapeutic drug monitoring and precision dosing and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of therapeutic drug monitoring and precision dosing; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Dose Proportionality Accumulation Time Dependency · malekokour bundle
Reviews Dose proportionality, accumulation, time dependency evidence pack for the L3 task «Dose proportionality, accumulation, time dependency». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Dose proportionality, accumulation, time dependency and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of dose proportionality, accumulation, time dependency; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Bioequivalence Statistics Tost Confidence Intervals · malekokour bundle
Reviews Bioequivalence statistics - TOST and confidence intervals evidence pack for the L3 task «Bioequivalence statistics - TOST and confidence intervals». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Bioequivalence statistics - TOST and confidence intervals and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of bioequivalence statistics - tost and confidence intervals; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Safety · malekokour bundle
Reviews For safety evidence pack for the L3 task «For safety». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for For safety and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of for safety; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Library Router · malekokour bundle
Selects which ClinPharm PMx Skills skill to run for a user or agent request inside this repository. Use when the task is ambiguous across skills, the user asks which skill to use, routing or skill selection is needed, or the host should ask/refuse instead of guessing. Classifies SIMPLE / SINGLE / AMBIGUOUS / MULTI, narrows by job-tree nav_path, then returns top-1 with reasons, asks the user, or refuses human-only/OOS/safety work. Example: "Which skill should handle reviewing this bioanalytical validation report?" Do not use to spawn multi-agent swarms, take clinical decisions, or bypass safety boundaries.

0
installs
▌
Review Obesity · malekokour bundle
Reviews Obesity evidence pack for the L3 task «Obesity». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Obesity and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of obesity; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Efficacy · malekokour bundle
Reviews For efficacy evidence pack for the L3 task «For efficacy». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for For efficacy and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of for efficacy; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Paediatric · malekokour bundle
Reviews Paediatric evidence pack for the L3 task «Paediatric». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Paediatric and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of paediatric; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Build Work Context · malekokour bundle
Builds, updates, refreshes, and exports portable work context for pharmaceutical and biotech professionals. Use this skill whenever someone wants AI to understand their pharma role, department, responsibilities, projects, sources, terminology, constraints, approval rules, or preferred deliverables; asks to be interviewed; mentions a work profile, professional constitution, project instructions, reusable context, Copilot or ChatGPT context, or wants to combine an existing context file with new project documents. Produces a professional context, project capsule, working pack, and change summary without inventing facts. Do not use for patient-specific clinical decisions or as a substitute for qualified scientific, regulatory, or medical judgment.

0
installs
▌
Verify Nca Outputs · malekokour bundle
Performs the reviewer side of the NCA dual-control pattern — verifying that reported non-compartmental parameters trace to the parameter dataset, that the analysis plan's exclusion, BLQ, lambda-z, unit and rounding rules were applied as written, and that summary statistics recompute from the per-subject values. Use this skill when someone asks to QC, verify, second-check or independently review an NCA output package, parameter tables or PK summary statistics before they are released to a study report — for example "QC the NCA outputs before they go into the CSR" or "check the exclusions and half-life estimation against the PK analysis plan". Do not use when the request is to review a report that merely quotes NCA values, to review bioanalytical assay validation, to rerun or re-derive the analysis, or to decide which of two conflicting values is scientifically correct.

0
installs
▌
Review Ddi Evidence · malekokour bundle
Structures one compound's DDI package from in-vitro results, clinical studies, models, labels and literature under ICH M12 logic. It builds a source-linked enzyme/transporter inventory, assigns perpetrator/victim roles, carries each signal to an auditable terminus, and drafts management wording for review. Use it to assemble, review or gap-check DDI evidence, inventory enzyme/transporter characterization, check whether a clinical interaction study is triggered, or draft report, summary or label language. Example: "Assemble and gap-check the DDI evidence package for this compound under ICH M12." Do not use for programme-level development-plan routing, biological relevance, assay adequacy, clinical significance, untested-pathway importance, dose selection or adjustment, or as a substitute for a curated interaction database.

0
installs
▌
Review Noael Hed Mrsd · malekokour bundle
Reviews NOAEL to HED to MRSD evidence pack for the L3 task «NOAEL to HED to MRSD». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for NOAEL to HED to MRSD and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of noael to hed to mrsd; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Ctd 272 Content · malekokour bundle
Reviews a draft Module 2.7.2 Summary of Clinical Pharmacology Studies against the fixed five-part ICH M4E(R2) structure, reconciles its dose content with Modules 2.7.3 and 2.7.4, and validates the Module 5 placement of every study it summarises. Use this skill when someone asks to review, QC, structure-check or reconcile a CTD 2.7.2 summary — for example "check our 2.7.2 against M4E before the dossier freeze" or "the dose in 2.7.2 and 2.7.4 do not match, find where". Do not use for reviewing USPI Section 12 or any labelling text, for running the full programme-wide document thread, or for any request to decide which conflicting dose or value is correct, to select a dose, or to approve a section.

0
installs
▌
Review Pk Analysis Plan · malekokour bundle
Reviews a PK analysis plan or the clinical pharmacology contribution to an SAP before the data exist. It traces objectives to planned analyses in both directions so an objective nobody planned to answer is caught before reporting, tests whether each analysis could be executed without a new decision and names the decisions it defers, checks that analysis populations are determinable from recorded data and that every analysis names one, and records the timing of each analysis relative to unblinding including for amendments. Use it before database lock, for an SAP contribution, or for a plan amendment. Example: "Please modelling analysis plans, for data-handling rules, for study objectives, for analysis outputs." Do not use for modelling analysis plans, for data-handling rules, for study objectives, for analysis outputs, or to decide which analysis is scientifically preferable.

0
installs
▌
Review Renal Impairment · malekokour bundle
Reviews Renal impairment evidence pack for the L3 task «Renal impairment». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Renal impairment and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of renal impairment; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Study Conduct Pk · malekokour bundle
Reviews an assembled pharmacokinetic data package prepared for a dose-escalation or safety-review committee, checking that it is internally consistent with the listings it was built from, complete against what it is required to contain, and consistent with the previous cohort's package — producing a source-linked register of open items for a qualified clinical pharmacologist. Use this skill when someone asks to check, QC or sanity-check an already-assembled cohort PK package, escalation-meeting slide pack or interim PK summary before a human reviewer takes it forward — for example "check the cohort 3 PK pack against the interim listings" or "is anything missing from this package". Do not use for verifying NCA derivations themselves, for reviewing the PK sections of a CSR, or for any request to recommend, support, justify or decide whether to escalate, hold or stop a dose — real-time escalation decisions are excluded from this skill entirely.

0
installs
▌
Prepare Meeting Strategy · malekokour bundle
Structures the clinical pharmacology input to an agency meeting strategy — identifying which CP topics warrant discussion, mapping each to the available meeting types (Type A/B/C for FDA; scientific advice, protocol assistance for EMA), and building the briefing package that supports the requested meeting type. Use when preparing or reviewing the CP contribution to a meeting request. Do not use for drafting the meeting request itself, for rehearsal coaching, or for taking a negotiating position.

0
installs
▌
Review Escalation Schema · malekokour bundle
Reviews the dose-escalation design of a first-in-human or early-phase study — increment sizes and what justifies them, sentinel and staggering arrangements against the mechanism's risk features, and whether stopping rules are specific enough to apply under pressure. It flags increments justified only by convention, levels whose predicted exposure passes the study's own exposure cap, and rules that require a judgment call rather than stating a trigger. Use it for an escalation schema in a protocol or amendment, or to prepare a design for safety-committee review. Example: "Please an escalation schema in a protocol or amendment." Do not use for starting-dose derivation, for nonclinical package adequacy, for late-phase dose-modification schemes, for deciding whether to escalate a live cohort, or to select or approve any dose.

0
installs
▌
Review Sample Size Power · malekokour bundle
Reviews Sample size and power evidence pack for the L3 task «Sample size and power». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Sample size and power and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of sample size and power; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Agent Based Models · malekokour bundle
Reviews Agent-based models evidence pack for the L3 task «Agent-based models». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Agent-based models and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of agent-based models; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Bioanalytical Plan · malekokour bundle
Reviews a bioanalytical plan before samples are collected - which analytes will be measured, in what matrix, over what calibration range, and whether that range covers the concentrations the study will actually produce. It derives required analytes from the objectives before reading the plan, compares the lower limit against predicted terminal concentrations rather than peak, checks long-term stability against the interval to the last analysis rather than the first, and flags points where the plan requires a judgment it does not constrain. Use it for a draft plan, a calibration range check, or a reanalysis plan. Example: "Please a draft plan, a calibration range check." Do not use for the bioanalytical report and its validation results, for sampling times, for multi-analyte conjugate strategy, or to accept the method.

0
installs
▌
Review Clinical Ddi Study · malekokour bundle
Reviews clinical drug-interaction study reports for design adequacy, result integrity and coverage against in-vitro triggers. It records the mechanism and index drug and flags mismatches, assesses whether the design could detect the effect it sought, extracts every geometric mean ratio with its confidence interval and classifies it against magnitude bands transcribed from the guidance in force, and separates inconclusive studies from negative ones. Use it to review a dedicated interaction study, check which triggered signals received a study, or reconcile a reported ratio against a summary or label. Example: "Review a dedicated interaction study, check which triggered signals received a study." Do not use for in-vitro package review, for management strategy or label wording, for re-analysing individual data, or to judge whether an exposure change is clinically significant.

0
installs
▌
Review Csr Pk Consistency · malekokour bundle
Reviews the pharmacokinetic content of a draft clinical study report against its own synopsis, tables, figures and permitted source outputs, with bounded CSR-local PD/biomarker context and topline snapshot routes, producing a source-linked discrepancy register and QC memo. Use when someone asks to check or reconcile one CSR against its own NCA, statistical, protocol, SAP, PD/biomarker, or locked topline sources. Route multi-document or programme-thread work to reconcile-cross-document-facts. Do not use for reviewing a protocol before a study runs, verifying derivations themselves, clinical interpretation, or deciding which conflicting value is scientifically correct.

0
installs
▌
Review Fih Dose Rationale · malekokour bundle
Reviews an already-written first-in-human starting-dose rationale — the most-sensitive-species argument, the NOAEL to HED to MRSD conversion chain, the MABEL consideration where the mechanism indicates one, and the escalation and stopping-rule skeleton — and recomputes every arithmetic step with a printed audit trail. Use this skill when someone asks to check, QC, verify or review an existing FIH dose rationale, IB dose-justification section or protocol starting-dose narrative — for example "does the HED in this IB recompute from the rat NOAEL" or "review the dose rationale before it goes to tox and the medical monitor". Do not use it to derive, select, propose, justify or approve a starting dose, to set or adjust an escalation increment, to judge whether a safety factor or staggering interval is adequate, or to prepare a registration-dose justification.

0
installs
▌
Review Hepatic Impairment · malekokour bundle
Reviews Hepatic impairment evidence pack for the L3 task «Hepatic impairment». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Hepatic impairment and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of hepatic impairment; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Interim Blinded Pk · malekokour bundle
Assesses a proposed interim or blinded look at accumulating PK data - what the protocol permits, what looking costs, and what the data can currently support. It distinguishes blinded, partially unblinded and fully unblinded review rather than letting one phrase cover all three, names who becomes conflicted by seeing the data since a person who has seen unblinded exposure cannot afterwards make a blinded judgment about an exclusion or amendment, assesses de-blinding risk in looks described as blinded, and states sample size alongside every interim estimate. Use it before a planned look or to build the access record. Example: "Please escalation committee packages, deviation impact, final analysis, the analysis plan." Do not use for escalation committee packages, deviation impact, final analysis, the analysis plan, or to make the interim decision.

0
installs
▌
Review Module 5 Placement · malekokour bundle
Reviews the placement of clinical study reports within CTD Module 5 — verifying that each study is filed in the correct subsection (5.3.1 through 5.3.5), that the filing structure matches the study types, and that the Module 5 table of contents is consistent with what actually appears. Use when asked to verify Module 5 organization before filing. Do not use for study content review, for 2.7.x summary review, or for deciding which studies to file.

0
installs
▌
Author Applicants Position · malekokour bundle
Drafts and reviews the clinical pharmacology applicant's-position sections of a regulatory briefing package — each position stated as a claim with its scope, the evidence that supports it, the pre-specified rule it rests on, its limitations, and its residual gaps — structured so that every position is auditable against the cited evidence and no position reads as agreed or accepted. Use this skill when someone asks to draft or review applicant's positions for a regulatory interaction, stress-test positions against their evidence, or check that every position is supported. Example: "Please to draft or review applicant's positions for a regulatory interaction, stress-test positions against their evidence." Do not use for the meeting-request letter itself, for responding to questions an agency already sent, for CTD summary content, for the question-set design, or for any request to assert that a position is agreed or will be accepted.

0
installs
▌
Review Eu Smpc Cp Sections · malekokour bundle
Reviews the clinical pharmacology content of a draft EU Summary of Product Characteristics — sections 4.2, 4.5, 5.2 and the quantitative statements in 4.4 — against the SmPC guideline's required content, the QRD template's section structure, and the source data each statement claims to rest on. Use this skill when someone asks to review, QC, check the structure of, or trace the numbers in draft SmPC clinical pharmacology content — for example "does 5.2 cover all the populations it needs to" or "trace every interaction magnitude in 4.5 back to its study". Do not use for drafting or rewording SmPC text, for US Prescribing Information, for Japanese package inserts, for a company core data sheet, for reviewing a Module 2.7.2 submission summary, or for any request to decide what the label should say.

0
installs
▌
Review Human Pk Prediction · malekokour bundle
Reviews a human pharmacokinetic prediction deliverable — allometric scaling, in vitro to in vivo extrapolation, or a PBPK model report — against the inputs it declares, the assumptions it states, and the qualification evidence it claims. Use this skill when someone asks to review, QC, or check the basis of a predicted human PK parameter, a first-in-human exposure projection, an IVIVE clearance estimate, or a PBPK model report — for example "does this PBPK report support the exposure it predicts" or "check the allometric exponent and what it was fitted on". Do not use to build, run, refit or re-parameterise a model, to select a first-in-human dose, to decide whether a prediction is scientifically correct, or to review a population PK analysis of observed clinical data.

0
installs
▌
Review Pmr Pmc Commitments · malekokour bundle
Reviews post-marketing requirement (PMR) and post-marketing commitment (PMC) wording, study designs, and timetables for clinical pharmacology content — verifying that each commitment is scientifically feasible as worded, that the proposed design answers the stated question, and that timetables are internally consistent. Use when reviewing draft PMR/PMC language before agreement with an agency. Do not use for PMR/PMC execution tracking, for post-approval change impact, or for deciding what to commit to.

0
installs
▌
Review Pregnancy Lactation · malekokour bundle
Reviews Pregnancy and lactation evidence pack for the L3 task «Pregnancy and lactation». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Pregnancy and lactation and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of pregnancy and lactation; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Oversee Nca Dual Control Qc · malekokour bundle
Establishes whether an NCA quality-control pass was structurally sound, rather than assuming it from the words dual control. It classifies independence on an explicit scale - same script rerun through to different software entirely - and records whether the checker saw the primary results first, expresses scope as denominators of parameters, subjects and pipeline stages covered, and flags discrepancies resolved by the primary analyst alone, which returns the deliverable to single control exactly when dual control mattered. Use it to set up or review dual-control arrangements, assess CRO QC documentation, or build the oversight record. Example: "Please set up or review dual-control arrangements, assess CRO QC documentation." Do not use for verifying NCA parameters, for data-handling rules, for bioanalytical data quality, or to accept the deliverable.

0
installs
▌
Review Adc Analyte Strategy · malekokour bundle
Reviews the analyte strategy for an antibody-drug conjugate — which analytes are measured, how each is defined, whether the set supports the exposure questions the programme asks, and whether reported parameters are internally consistent across analytes. Use this skill when someone asks to review, QC, or check the PK characterisation plan or results for an ADC or other multi-analyte modality — for example "does this analyte set support a DAR-shift question" or "check that total antibody and conjugated payload are consistently defined across these documents". Do not use to select an analyte strategy, to decide whether an analyte is scientifically necessary, to review bioanalytical method validation, or to review a single-analyte small-molecule programme.

0
installs
▌
Review Bioanalytical Report · malekokour bundle
Reviews the content of a bioanalytical method validation report and its study sample analysis report against the shared ICH M10 conformance rubric, producing an element-by-element conformance register plus the subset of observations that bear on PK interpretation. Use this skill when someone asks whether a bioanalytical report covers what the standard requires, or whether its stated stability, dilution, carryover and reanalysis content supports the PK data drawn from it — for example "check this validation report against ICH M10" or "does the bioanalytical package support the concentrations behind these PK parameters". Do not use for verifying NCA derivations or parameter values, for reconciling a study report against its own sources, for re-validating or re-fitting the assay, or for any request to certify GLP or GCP compliance or to declare a method acceptable.

0
installs
▌
Review In Vitro Ddi Package · malekokour bundle
Reviews an in-vitro drug-interaction package for completeness, internal consistency and decision-readiness. It inventories which enzymes and transporters were assessed and which were not, classifies every reported inhibition and induction parameter against thresholds transcribed from the guidance in force, sums fraction metabolised with an explicit unassigned remainder, and lists every signal above threshold that has no terminus. Use it to gap-check reaction phenotyping, transporter assessment or an in-vitro report before it supports a development decision. Example: "Please gap-check reaction phenotyping, transporter assessment or an in-vitro report before it supports a development decision." Do not use for clinical interaction studies, for management strategy or label wording, or to judge whether an interaction is clinically significant.

0
installs
▌
Review Protocol Pk Sections · malekokour bundle
Reviews the clinical pharmacology content of a study protocol or amendment — dose rationale, PK/PD sampling, bioanalysis, subject restrictions, embedded PK analysis, and consent-document consistency for PK/genomic procedures — producing a source-located open comment list for qualified review. Use when asked to review or comment on CP/PK protocol sections before a study runs, or to reconcile protocol/sample/consent versions and procedure presence. Do not use to judge consent adequacy, vulnerability or capacity, QC a completed study report, verify NCA derivations, or select, adjust, justify, or endorse a dose.

0
installs
▌
Review Qt Concentration Qtc · malekokour bundle
Reviews QT and concentration-QTc evidence pack for the L3 task «QT and concentration-QTc». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for QT and concentration-QTc and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of qt and concentration-qtc; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Assess Development Plan Gaps · malekokour bundle
Assesses a clinical pharmacology development plan against guidance-anchored evidence expectations, classifying every expected element as present, triggered, waivable-with-rationale, or a residual gap, each traced to the criterion that creates the obligation. Use this skill when someone asks what clinical pharmacology evidence a programme is still missing, whether a plan covers what a reviewer will expect, or which studies the drug's own properties have made obligatory — for example "what CP work are we still missing before the pre-NDA meeting" or "does this plan cover the renal and hepatic expectations". Do not use for reviewing one interaction package, for assembling agency-facing briefing content, or for any request to decide whether a gap is acceptable, to commit to a study, or to approve a plan.

0
installs
▌
Map Agency Question Evidence · malekokour bundle
Triages a received health-authority information request into atomic answerable units and maps each unit to its source evidence, its gaps, and a proposed owner, with completeness reported as a fraction against both the request itself and the standard clinical pharmacology question battery. Use this skill when someone asks to break down, triage, map, track or check coverage of an agency question, information request, list of questions, request for supplementary information or meeting-minute action — for example "split this IR into answerable parts and tell me what evidence we already have" or "check our draft response cites something that actually resolves". Do not use for preparing a briefing package we choose to send, for authoring the scientific answer to a question, for deciding which of two conflicting values is correct, or for predicting what an authority will ask next.

0
installs
▌
Review Biomarker Fit Purpose · malekokour bundle
Reviews Biomarker fit-for-purpose evidence pack for the L3 task «Biomarker fit-for-purpose». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Biomarker fit-for-purpose and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of biomarker fit-for-purpose; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Competitive Landscape · malekokour bundle
Reviews Competitive landscape evidence pack for the L3 task «Competitive landscape». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Competitive landscape and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of competitive landscape; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Immunogenicity Assays · malekokour bundle
Reviews Immunogenicity assays evidence pack for the L3 task «Immunogenicity assays». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Immunogenicity assays and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of immunogenicity assays; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Label Differentiation · malekokour bundle
Reviews Label differentiation evidence pack for the L3 task «Label differentiation». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Label differentiation and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of label differentiation; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Uspi Section 2 Dosing · malekokour bundle
Reviews US prescribing information Section 2 dosing content against the evidence behind it, in both directions. It traces every dose adjustment to a supporting exposure finding and checks direction and magnitude rather than the presence of a citation, then runs the reverse check that finds the real defects - exposure findings with neither an instruction nor an explicit statement that no adjustment is needed. It also checks administration conditions against the biopharmaceutics evidence and compares the Highlights dosing summary against the full section. Use it for draft or approved Section 2 content, or a proposed dosing change. Example: "Please draft or approved Section 2 content." Do not use for Section 12 content, for Section 7 interaction entries, for registration dose justification, for non-US labels, for drafting wording, or to select or approve any dose or adjustment.

0
installs
▌
Review Modality Applicability · malekokour bundle
Reviews Modality applicability evidence pack for the L3 task «Modality applicability». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Modality applicability and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of modality applicability; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Pkpd Sampling Schedule · malekokour bundle
Reviews a PK or PD sampling schedule before a study fixes it, mapping each objective to the parameters it requires and reporting which the schedule cannot characterise. It assesses peak coverage as bracketing rather than a single sample at a predicted Tmax the study exists to test, states how many terminal-phase points are expected above the quantification limit and where that expectation came from, checks a PD schedule against the effect time course rather than the PK times, and flags sample times with no allowed window because those generate deviations by construction. Use it for a draft schedule, a sparse design, or a schedule change in an amendment. Example: "Please a draft schedule, a sparse design." Do not use for study objectives, protocol sections generally, bioanalytical method review, analysis specification, or to approve the schedule.

0
installs
▌
Review Registry Real World Pk · malekokour bundle
Reviews Registry and real-world PK evidence pack for the L3 task «Registry and real-world PK». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Registry and real-world PK and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of registry and real-world pk; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Prepare Position Defence Brief · malekokour bundle
Structures a clinical pharmacology position defence brief — the evidence-backed argument for a CP position the team expects to defend before an agency. Maps the position statement to its evidence chain, identifies vulnerabilities, and assembles counter-arguments with sourced data. Use when preparing a CP position for agency discussion. Do not use for drafting the position itself, for deciding the position, or for predicting what an agency will accept.

0
installs
▌
Reconcile Cross Document Facts · malekokour bundle
Maintains a register of clinical pharmacology values and claims across a programme's document thread — protocol, CSR, Module 2.7.2, briefing documents and label — and supports bounded privacy structure, ethics-submission, topline snapshot, and PD/biomarker context tracing. Use when a request spans documents or studies over time, asks where a changed value propagates, or traces declared PD/biomarker fields, synthetic privacy structures, ethics records, or topline facts across a programme. Example: "Where does this changed clearance value propagate across the CSR, Module 2.7.2 and the draft label?" Do not use for participant records, legal/privacy compliance, ethics approval or response adequacy, checking one report against its own outputs, verifying an analysis, drafting source documents, clinical meaning, causality, benefit-risk, disclosure wording, commitments, or deciding which conflicting value is correct.

0
installs
▌
Review Adme Routes Elimination · malekokour bundle
Reviews ADME and routes of elimination evidence pack for the L3 task «ADME and routes of elimination». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for ADME and routes of elimination and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of adme and routes of elimination; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Company Core Data Sheet · malekokour bundle
Reviews the clinical pharmacology content of a Company Core Data Sheet (CCDS) — the sponsor's internal reference document that anchors all regional label variants. Checks that CP content is consistent with the authoritative evidence base, that it can support downstream regional labels (USPI, SmPC, JP PI), and that content differences between CCDS and regional labels are documented rather than silent. Use when reviewing a CCDS draft. Do not use for regional label review or for deciding what content to include.

0
installs
▌
Review Due Diligence Licensing · malekokour bundle
Reviews Due diligence and in-licensing evidence pack for the L3 task «Due diligence and in-licensing». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Due diligence and in-licensing and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of due diligence and in-licensing; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Exposure Safety Margins · malekokour bundle
Reviews stated exposure safety margins — the ratio between a nonclinical no-observed-adverse-effect exposure and a clinical exposure — for whether each margin's basis is stated, its two sides are comparable, and its arithmetic reconciles. Use this skill when someone asks to review, QC, or trace a safety margin, a DILI or organ-toxicity exposure margin, or an exposure-based safety statement — for example "check the hepatic margin in the IB against the tox report" or "does every stated margin say which exposure metric and species it uses". Do not use to decide whether a margin is adequate, to set an exposure cap or stopping rule, to select a dose, to interpret a safety signal, or to review the toxicology study itself.

0
installs
▌
Review Uspi Section 12 Content · malekokour bundle
Reviews Section 12 of a draft US Prescribing Information, and the quantitative basis of the statements in Sections 2, 7 and 8, against 21 CFR 201.57(c)(13), the December 2016 clinical pharmacology labelling guidance, and the source data each statement claims to rest on. Use this skill when someone asks to review, QC, check conformance of, or trace the numbers in draft labelling clinical pharmacology content — for example "does Section 12.3 carry everything the content list requires" or "trace every number in Section 8 back to its source". Do not use for drafting or rewording label text, for reviewing a Module 2.7.2 submission summary, for advising on or responding to an agency labelling comment, or for any request to decide what the label should say.

0
installs
▌
Assess Pharmacogenomic Evidence · malekokour bundle
Assesses whether pharmacogenomic covariate effects are characterised across the programme's evidence base — in-vitro enzyme and transporter genotype data, PopPK covariate analyses, dedicated PGx sub-studies, and the labelling concept — producing a gene-enzyme-phenotype register in which every stated PGx effect traces to its source and every source-identified polymorphism traces to its downstream statement. Use this skill when someone asks whether pharmacogenomic effects are characterised for a compound, whether a PopPK analysis covers the relevant polymorphisms, or what PGx gaps remain. Example: "Please pharmacogenomic effects are characterised for a compound." Do not use for demographic covariates (age, sex, body size), for organ-impairment characterisation, for drug-drug interaction assessment, or for any request to recommend a genotype-based dose adjustment.

0
installs
▌
Prepare Assessment Aid Position · malekokour bundle
Structures the clinical pharmacology content of an assessment aid or applicant's position document — the tabulated summary an agency requests to facilitate their review. Extracts every CP claim, traces it to its source document, verifies internal consistency, and flags any position statement that crosses into a clinical or regulatory decision. Use when asked to prepare or review an assessment aid's CP section. Do not use for drafting agency responses, for meeting preparation, or for taking a position.

0
installs
▌
Prepare Midd Engagement Package · malekokour bundle
Assembles and reviews the clinical pharmacology content of a Model-Informed Drug Development (MIDD) regulatory engagement package — the modelling question, the model context of use, the qualification or fitness-for-purpose argument, the key assumptions with their sensitivity analyses, and the decision the model output informs — structured so that every element traces to its source and no model-derived conclusion is stated as a fact. Use this skill when someone asks to assemble or review a MIDD engagement package, check that a modelling position is fit-for-purpose-ready, or map model assumptions to their evidence. Example: "Please to assemble or review a MIDD engagement package, check that a modelling position is fit-for-purpose-ready." Do not use for running or fitting a model, for writing the model analysis plan, for reviewing one PopPK or PBPK report for internal consistency, or for any request to decide whether a model is qualified or whether its output justifies a dose.

0
installs
▌
Review Ctd 2 7 6 Study Synopses · malekokour bundle
Reviews CTD Module 2.7.6 individual study synopses for completeness against their parent study reports and consistency with Module 2.7.1-2.7.4 summaries. Checks that every study in the clinical development programme has a synopsis, that each synopsis carries the ICH E3-mandated elements, and that key parameter values agree with the full report. Use when asked to QC synopses before filing. Do not use for full CSR review, for Module 5 placement, or to decide which studies to include.

0
installs
▌
Review Ctd 2734 Exposure Safety · malekokour bundle
Reviews CTD 2.7.3.4 and 2.7.4 exposure-safety content against the analyses behind it. It traces every stated relationship to its analysis in both directions, so an omitted analysis is caught as well as an unsupported claim, treats a negative statement as a claim requiring evidence rather than an absence of one, and reports underpowered negatives separately from supported negatives because the two read identically and mean the opposite. It also checks exposure metric and analyte coherence against the clinical pharmacology summary. Use it for draft or filed exposure-safety sections, or to prepare an agency response. Example: "Please draft or filed exposure-safety sections." Do not use for CTD 2.7.2 content, for nonclinical exposure margins, for benefit-risk structure, for drafting the section, or to decide whether a relationship is clinically meaningful.

0
installs
▌
Review Dose Modification Scheme · malekokour bundle
Reviews a proposed dose-modification scheme — every rule's trigger, threshold, direction, and cited evidence — checking that each rule traces to an analysis, that the threshold matches its source, that the direction is consistent with the exposure change, and that the rule set is internally consistent and covers the populations the labelling concept names. Use this skill when someone asks to review dose-modification rules, check whether each rule is evidence-backed, reconcile modification thresholds across documents, or assess whether the rule set covers the populations it should. Example: "Please to review dose-modification rules, check whether each rule is evidence-backed, reconcile modification thresholds across documents." Do not use for selecting or proposing a dose modification, for reviewing the full dose justification evidence package, for the MIDD engagement package, for label review, or for any request to set, adjust, or endorse a threshold or a dose.

0
installs
▌
Review Immunogenicity Impact Pk · malekokour bundle
Reviews Immunogenicity impact on PK evidence pack for the L3 task «Immunogenicity impact on PK». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Immunogenicity impact on PK and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of immunogenicity impact on pk; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Assess Protocol Amendment Impact · malekokour bundle
Assesses what a protocol amendment does to data a running study has already produced and to what the study can still conclude. It states enrolment at the time of amendment because impact scales with it, assesses poolability per analysis rather than once for the study - a sampling change is often poolable for population modelling and not for non-compartmental parameters - names objectives that become unanswerable rather than letting them surface at reporting, and builds the propagation list from the dependent documents rather than the amendment cover note. Use it before implementation, to settle poolability, or to reconstruct an implemented amendment. Example: "Please unplanned deviations, sampling schedule adequacy, analysis plan amendments specifically." Do not use for unplanned deviations, sampling schedule adequacy, analysis plan amendments specifically, or to approve the amendment.

0
installs
▌
Prepare Briefing Package Content · malekokour bundle
Drafts and reviews the clinical pharmacology portion of a regulatory briefing package — answerable questions to the agency, applicant positions with their supporting evidence, and validated annex cross-references — aligned to the public structure of clinical pharmacology review. Use this skill when someone asks to draft, structure, stress-test or QC the CP content of a briefing book or meeting package — for example "draft the clin pharm section of our pre-NDA briefing package", "which questions should we ask", or "check every position in this package is actually supported". Do not use for responding to questions an agency has already sent, for writing the meeting request itself, for CTD summary or labelling content, or for any request to decide whether a position will be accepted.

0
installs
▌
Review AI Ml Workflow Automation · malekokour bundle
Reviews AI/ML workflow automation evidence pack for the L3 task «AI/ML workflow automation». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for AI/ML workflow automation and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of ai/ml workflow automation; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Ctd 2 5 Clinical Overview · malekokour bundle
Reviews the clinical pharmacology content of a CTD Module 2.5 Clinical Overview — the integrated narrative that places pharmacokinetic, pharmacodynamic, dose-selection, DDI, and special-population evidence into the benefit-risk context. Checks that every quantitative claim traces to a source in Modules 2.7.1-2.7.4 or 5, that the dose rationale is stated and sourced, and that the overview does not contradict its summaries. Use when asked to review or gap-check a 2.5 draft's CP content. Do not use for Module 2.7.2 detail review, for label review, or for drafting the overview.

0
installs
▌
Review Dose Ranging Design Input · malekokour bundle
Reviews Dose-ranging design input evidence pack for the L3 task «Dose-ranging design input». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Dose-ranging design input and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of dose-ranging design input; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Drug Utilisation Outcomes · malekokour bundle
Reviews Drug utilisation and outcomes evidence pack for the L3 task «Drug utilisation and outcomes». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Drug utilisation and outcomes and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of drug utilisation and outcomes; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Fixed Weight Based Dosing · malekokour bundle
Reviews Fixed versus weight-based dosing evidence pack for the L3 task «Fixed versus weight-based dosing». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Fixed versus weight-based dosing and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of fixed versus weight-based dosing; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Metabolite Profiling Mist · malekokour bundle
Reviews Metabolite profiling and MIST evidence pack for the L3 task «Metabolite profiling and MIST». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Metabolite profiling and MIST and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of metabolite profiling and mist; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Midd Plan Model Inventory · malekokour bundle
Reviews MIDD plan and model inventory evidence pack for the L3 task «MIDD plan and model inventory». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for MIDD plan and model inventory and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of midd plan and model inventory; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Model Based Meta Analysis · malekokour bundle
Reviews Model-based meta-analysis evidence pack for the L3 task «Model-based meta-analysis». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Model-based meta-analysis and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of model-based meta-analysis; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Paediatric Dose Selection · malekokour bundle
Reviews Paediatric dose selection evidence pack for the L3 task «Paediatric dose selection». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Paediatric dose selection and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of paediatric dose selection; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Biosimilar Generic Defence · malekokour bundle
Reviews Biosimilar and generic defence evidence pack for the L3 task «Biosimilar and generic defence». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Biosimilar and generic defence and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of biosimilar and generic defence; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Ctd 2 7 1 Biopharmaceutics · malekokour bundle
Reviews a CTD Module 2.7.1 Summary of Biopharmaceutics Studies against ICH M4E structure requirements and the underlying study reports. Checks that every biopharmaceutics study cited in the summary is present and traceable, that formulation chronology is stated, that the BCS class justification is sourced, and that dissolution-PK links are consistent. Use when asked to review, QC, or gap-check a 2.7.1 draft before filing. Do not use for the biopharmaceutics content inside a CSR, for BA/BE study design review, for formulation bridging strategy, or for any section of Module 5.

0
installs
▌
Review Dialysis Organ Replacement · malekokour bundle
Reviews Dialysis and organ replacement evidence pack for the L3 task «Dialysis and organ replacement». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Dialysis and organ replacement and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of dialysis and organ replacement; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Model Analysis Deliverable · malekokour bundle
Reviews a model analysis plan or report — population PK, PBPK, exposure–response or another model-informed deliverable — against its own stated questions, assumptions, pre-stated evaluation criteria and presented evidence, using the shared review-rubric library. Use this skill when someone asks to review, QC or gap-check a modelling plan or modelling report for completeness, traceability and internal consistency — for example "does this popPK report answer the question it was commissioned for" or "check this PBPK report against the format and content expectations". Do not use for verifying NCA derivations, for reviewing a CTD 2.7.2 summary, or for any request to re-fit, re-run, critique or improve the model itself.

0
installs
▌
Review Oncology Dose Optimisation · malekokour bundle
Reviews Oncology dose optimisation evidence pack for the L3 task «Oncology dose optimisation». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Oncology dose optimisation and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of oncology dose optimisation; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Overdose Antidote Guidance · malekokour bundle
Reviews Overdose and antidote guidance evidence pack for the L3 task «Overdose and antidote guidance». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Overdose and antidote guidance and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of overdose and antidote guidance; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Post Approval Label Update · malekokour bundle
Assesses a proposed change to an approved US label. It maps which other sections carry a fact the change alters and flags any the proposal omits, checks whether the proposed wording is stronger or weaker than the evidence behind it, and runs the check nobody runs - whether statements that are staying unchanged are still true afterwards, since new evidence can make an untouched sentence wrong. It also separates evidence-driven changes from changes required only because another section moved. Use it for a post-approval label supplement, an agency-requested revision, or working out the blast radius of a proposed edit. Example: "Please a post-approval label supplement, an agency-requested revision." Do not use for first-version label content, for non-US labels, for drafting wording, for negotiating with the agency, or to decide whether evidence warrants a change.

0
installs
▌
Review Signals Exposure Component · malekokour bundle
Reviews Signals with an exposure component evidence pack for the L3 task «Signals with an exposure component». Produces a source-linked finding register with denominators and an explicit refuse list. Use when a practitioner asks to work this topic — e.g. "Please review the materials for Signals with an exposure component and produce a sourced finding register \u2014 do not decide the clinical or regulatory outcome.". Do not use to decide the outcome of signals with an exposure component; approve or submit related documents; select or adjust a dose; speak for the sponsor to an agency.

0
installs
▌
Review Uspi Section 8 Populations · malekokour bundle
Reviews the clinical pharmacology content of a US Prescribing Information Section 8 (Use in Specific Populations) — verifying that each population subsection carries statements traceable to PK, PD, or modelling data, that dose modifications in Section 2 are consistent with Section 8 findings, and that the populations studied are represented. Use when asked to review or QC Section 8 CP content. Do not use for Section 12 review, for SmPC population sections, or for deciding dose modifications.

0
installs
▌
Assess Special Population Strategy · malekokour bundle
Assesses the completeness and internal consistency of a programme's special-population evidence strategy — renal impairment, hepatic impairment, paediatrics, pregnancy and lactation, elderly, and other defined sub-populations — against the programme's declared scope, the target product profile, and the guidance-anchored criteria that create study or analysis obligations for each population. Use this skill when someone asks whether the special-population strategy covers what a reviewer will expect, which populations still need characterisation, or whether the strategy documents are internally consistent. Example: "Please the special-population strategy covers what a reviewer will expect, which populations still need characterisation." Do not use for reviewing one organ-impairment study report, for demographic covariate assessment in a PopPK, for pharmacogenomic characterisation, or for any request to decide whether a waiver rationale is sufficient or to commit to a study.

0
installs

151 published skills · page 1 of 2